NYSE - Nasdaq Real Time Price • USD
The Cigna Group (CI)
As of 12:26 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 24 | 23 |
| Avg. Estimate | 6.22 | 6.93 | 28.43 | 32.02 |
| Low Estimate | 6.04 | 6.66 | 28.2 | 31.42 |
| High Estimate | 6.54 | 7.75 | 29.04 | 32.73 |
| Year Ago EPS | 5.41 | 6.13 | 25.09 | 28.43 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 21 | 21 |
| Avg. Estimate | 56.52B | 58.45B | 235.5B | 245.73B |
| Low Estimate | 55.57B | 57.34B | 231.11B | 234.03B |
| High Estimate | 57.75B | 61.05B | 245.61B | 251.5B |
| Year Ago Sales | 46.48B | 48.62B | 195.26B | 235.5B |
| Sales Growth (year/est) | 21.60% | 20.20% | 20.60% | 4.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 5.22 | 6.02 | 6.67 | 6.53 |
| EPS Actual | 5.41 | 6.13 | 6.77 | 6.79 |
| Difference | 0.19 | 0.11 | 0.1 | 0.26 |
| Surprise % | 3.60% | 1.80% | 1.50% | 4.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 6.22 | 6.93 | 28.43 | 32.02 |
| 7 Days Ago | 6.22 | 6.93 | 28.44 | 32.02 |
| 30 Days Ago | 6.21 | 6.92 | 28.43 | 32.05 |
| 60 Days Ago | 6.21 | 6.94 | 28.41 | 32.04 |
| 90 Days Ago | 6.37 | 6.91 | 28.29 | 31.6 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 2 | 2 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| CURRENCY IN USD | CI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 15.00% | -- | -- | 1.50% |
| Next Qtr. | 13.10% | -- | -- | 12.10% |
| Current Year | 13.30% | -- | -- | 4.40% |
| Next Year | 12.60% | -- | -- | 13.20% |
| Next 5 Years (per annum) | 11.95% | -- | -- | 10.97% |
| Past 5 Years (per annum) | 12.99% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 4/10/2024 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 3/8/2024 |
| Maintains | UBS: Buy to Buy | 3/8/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 3/8/2024 |
| Reiterates | Truist Securities: Buy to Buy | 3/8/2024 |
| Maintains | Mizuho: Buy to Buy | 3/8/2024 |
Related Tickers
HUM Humana Inc.
308.25
-1.02%
ELV Elevance Health, Inc.
537.28
-0.45%
CNC Centene Corporation
73.41
-3.00%
MOH Molina Healthcare, Inc.
344.58
-2.19%
UNH UnitedHealth Group Incorporated
494.43
+0.11%
CVS CVS Health Corporation
67.25
-0.13%
OSCR Oscar Health, Inc.
17.70
-1.06%
ALHC Alignment Healthcare, Inc.
5.15
-0.19%
NEUE NeueHealth, Inc.
6.04
-4.65%
CLOV Clover Health Investments, Corp.
0.6809
+1.63%